Short CommunicationEnhancement of maximal activation of neuronal nitric oxide synthase at muscarinic M1 receptors following prolonged agonist treatment
Introduction
The effects of nitric oxide (NO) on blood vessels and cGMP formation have long been known before it was discovered that it can be produced endogenously by a group of enzymes called NO synthases (Ignarro et al., 1981; Palmer et al., 1987, Palmer et al., 1988). NO also has diverse effects on neurons, and it has been shown to play an important role in learning (Dinerman et al., 1994), neurotoxicity (Nowicki et al., 1991; Dawson, 1994) and in regulation of neuronal excitability (Bagetta et al., 1992). Three isoforms of NO synthase have been cloned. Two isoforms are constitutive and their activity is Ca2+-calmodulin dependent (Bredt and Snyder, 1990). These enzymes are expressed predominantly in neuronal and endothelial cells (Bredt and Snyder, 1992). The third is Ca2+ independent and its expression is induced by agents such as gamma-interferon and tumor necrosis factor and by foreign agents such as bacterially-derived lipopolysaccharides (Bredt and Snyder, 1994).
Recent evidence, however, has shown that the activity of neuronal NO synthase is not purely constitutive, since the level of expression of the enzyme is altered under certain conditions. These conditions include brain lesions (Yu, 1994) and ischemia (Kato et al., 1994). Since NO is not stored in neurons, its rate of formation is dependent on the level of activity of neuronal NO synthase, which in turn is dependent on the level of expression of the enzyme. In this report we used Chinese hamster ovary (CHO) cells which co-express M1 muscarinic receptors and neuronal NO synthase to investigate whether the activity of this important enzyme is modulated by prolonged receptor activation. Our data demonstrate that maximal activation of neuronal NO synthase by M1 muscarinic receptors is markedly potentiated following long-term exposure to the muscarinic agonist carbachol.
Section snippets
Materials
[] l-arginine was obtained from Amersham (Arlington Heights, IL). Carbachol and pirenzepine were purchased from Sigma Chemicals (St. Louis, MO).
Cell culture
Chinese hamster ovary (CHO) cells that stably express human muscarinic M1 receptors were donated by Dr. M. Brann (University of Vermont). These cells were stably transfected with the neuronal NO synthase gene obtained from S.H. Snyder (John Hopkins University). CHO transfects were grown in Dulbecco's modified Eagle's medium (Gibco, Gaithersburg, MD)
Results
CHO cells which co-express M1 muscarinic receptors and neuronal NO synthase were preincubated in culture flasks with varying concentrations of carbachol for 48 h at 37°C. At the end of preincubation, cells were harvested and each group was incubated with [] l-arginine with or without 100 μM carbachol for 1 h at 37°C. [] l-citrulline formation was assayed as described in Section 2. Pretreatment with carbachol resulted in a concentration-dependent potentiation of subsequent agonist-induced
Discussion
Preliminary studies show that pretreatment with 3.3 μM or 1 mM carbachol for 48 h both resulted in a marked increase in the expression of neuronal NO synthase. However, pretreatment of CHO cells with either concentration of carbachol was also accompanied by significant reduction in muscarinic receptor density, dampening of receptor-mediated generation of inositol phosphates and desensitization of the Ca2+ response to carbachol (Cuadra, unpublished data). These findings might explain the
Acknowledgements
The authors thank Sheng Zu Zhu for the preparation of the transfected cell line used in this study. This work was supported by NIH grant NS25743.
References (18)
- et al.
Tacrine-induced seizures and brain damage in LiCl-treated rats can be prevented by N omega-nitro-l-arginine methyl ester
Eur. J. Pharmacol.
(1992) - et al.
Lithium and tacrine increase the expression of nitric oxide synthase mRNA in the hippocampus of rat
Biochem. Biophys. Res. Commun.
(1993) - et al.
Systemic administration of lithium chloride and tacrine increases nitric oxide synthase activity in the hippocampus of rats
Eur. J. Pharmacol.
(1993) - et al.
Nitric oxide, a novel neuronal messenger
Neuron
(1992) - et al.
Induction of NADPH-diaphorase activity in the hippocampus in a rat model of cerebral ischemia and ischemic tolerance
Brain Res.
(1994) - et al.
The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimers disease
Mayo Clin. Proc.
(1991) - et al.
Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse
Eur. J. Pharmacol.
(1991) - et al.
The neurotoxicity of subchronic acetylcholinesterase (AChE) inhibition in rat hippocampus
Toxicol. Appl. Pharmacol.
(1990) - et al.
Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme
Proc. Natl. Acad. Sci. USA
(1990)